Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in Biomarker-Guided Study of DB102 for Newly-Diagnosed Glioblastoma

americanpharmaceuticalreviewJanuary 15, 2021

Tag: DB102 , glioblastoma , Denovo Biopharma , GBM , cancer

PharmaSources Customer Service